OptiBiotix Health Management
Management criteria checks 4/4
OptiBiotix Health's CEO is Stephen O'Hara, appointed in Mar 2012, has a tenure of 12.75 years. total yearly compensation is £147.00K, comprised of 93.9% salary and 6.1% bonuses, including company stock and options. directly owns 10.43% of the company’s shares, worth £1.81M. The average tenure of the management team and the board of directors is 2.8 years and 6.9 years respectively.
Key information
Stephen O'Hara
Chief executive officer
UK£147.0k
Total compensation
| CEO salary percentage | 93.9% |
| CEO tenure | 12.8yrs |
| CEO ownership | 10.4% |
| Management average tenure | 2.8yrs |
| Board average tenure | 6.9yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£3m |
| Mar 31 2024 | n/a | n/a | -UK£3m |
| Dec 31 2023 | UK£147k | UK£138k | -UK£2m |
| Sep 30 2023 | n/a | n/a | -UK£8m |
| Jun 30 2023 | n/a | n/a | -UK£13m |
| Mar 31 2023 | n/a | n/a | -UK£5m |
| Dec 31 2022 | UK£151k | UK£143k | UK£3m |
| Sep 30 2022 | n/a | n/a | UK£4m |
| Jun 30 2022 | n/a | n/a | UK£6m |
| Mar 31 2022 | n/a | n/a | UK£6m |
| Dec 31 2021 | UK£262k | UK£254k | UK£6m |
| Sep 30 2021 | n/a | n/a | UK£13m |
| Jun 30 2021 | n/a | n/a | UK£21m |
| Mar 31 2021 | n/a | n/a | UK£13m |
| Dec 31 2020 | UK£229k | UK£218k | UK£6m |
| Dec 31 2019 | UK£229k | UK£248k | -UK£2m |
| May 31 2019 | n/a | n/a | -UK£2m |
| Feb 28 2019 | n/a | n/a | -UK£2m |
| Nov 30 2018 | UK£213k | UK£213k | -UK£2m |
Compensation vs Market: Stephen's total compensation ($USD184.85K) is below average for companies of similar size in the UK market ($USD347.06K).
Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.
CEO
Stephen O'Hara (64 yo)
12.8yrs
Tenure
UK£147,000
Compensation
Mr. Stephen Patrick O'Hara Founded OptiBiotix Health plc in March 2012 and serves as its Chief Executive. He also serves as the Board Director of ProBiotix Health Plc since April 26, 2018. Mr. O'Hara serve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 12.8yrs | UK£147.00k | 10.43% £ 1.8m | |
| Executive Director of Research & Development and Executive Director | no data | UK£47.00k | no data | |
| Acting Finance Director | less than a year | no data | no data | |
| Head of Operations & Quality | 2.9yrs | no data | no data | |
| Corporate Development Director | no data | no data | no data | |
| Marketing Director | 2.8yrs | no data | no data | |
| Secretary | no data | no data | no data |
2.8yrs
Average Tenure
60yo
Average Age
Experienced Management: OPTI's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 10.3yrs | UK£147.00k | 10.43% £ 1.8m | |
| Executive Director of Research & Development and Executive Director | 6.4yrs | UK£47.00k | no data | |
| Non-Executive Director | 6.3yrs | UK£20.00k | 0.15% £ 26.6k | |
| Member of Scientific Advisory Group | 8.9yrs | no data | no data | |
| Non-Executive Chairman | 6.9yrs | UK£44.00k | 0.51% £ 89.3k |
6.9yrs
Average Tenure
65.5yo
Average Age
Experienced Board: OPTI's board of directors are considered experienced (6.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 09:16 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OptiBiotix Health Plc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Donnellan | Cavendish Historical (Cenkos Securities) |